Table 1.
Baseline Demographic, Risk Factor and Risk Measure Characteristics According to Race/Ethnicity Groupa
| Characteristics | All (N=42 224) | Whites (N=38 277) | Asians (N=1621) | Blacks (N=977) | Hispanics (N=1349) |
|---|---|---|---|---|---|
| Demographic characteristics | |||||
| Age, y | 54.7±10.6 | 54.8±10.5 | 53.8±11.2 | 55.0±11.4 | 52.9±10.8 |
| Men, % | 65.0 | 65.3 | 63.7 | 60.0 | 61.5 |
| Risk factors | |||||
| Hypertension, % | 29.9 | 28.6 | 37.1 | 54.9 | 38.0 |
| Hyperlipidemia, % | 58.4 | 58.6 | 52.1 | 57.5 | 57.8 |
| Current smoker, % | 9.6 | 9.6 | 7.5 | 14.9 | 10.0 |
| Family history of CHD, % | 49.7 | 50.2 | 45.5 | 42.4 | 45.0 |
| Diabetes mellitus, % | 6.3 | 5.4 | 11.7 | 17.3 | 18.2 |
| Total cholesterol, mg/dL | 200.2±42.4 | 200.7±42.2 | 197.4±45.1 | 191.2±42.6 | 197.3±45.1 |
| HDL‐C, mg/dL | 54.0±18.3 | 54.1±18.4 | 53.4±18.5 | 53.1±17.4 | 50±15.5 |
| Systolic blood pressure, mm Hg | 127.3±19.0 | 127.2 ±19.0 | 123.8±19.0 | 131.8±17.6 | 129.0±20.4 |
| Risk measures | |||||
| Framingham risk score | 11.3±9.1 | 11.2±9.0 | 12.1±10.7 | 12.1±10.5 | 11.7 ±10.0 |
| ASCVD risk scoreb | 7.5±8.9 | 7.4±8.8 | 8.0±10.3 | 10.3±9.1 | 7.6±9.1 |
| ASCVD risk categories, % | |||||
| <5% | 54.7 | 55.2 | 56.4 | 32.1 | 54.0 |
| 5%–7.5% | 13.4 | 13.4 | 11.9 | 17.4 | 13.1 |
| >7.5% | 32.0 | 31.5 | 31.7 | 50.5 | 32.9 |
| CAC score categories, % | |||||
| CAC 0 | 44.5 | 44.2 | 49.0 | 43.9 | 46.0 |
| CAC 1–99 | 30.7 | 30.7 | 28.6 | 32.9 | 31.9 |
| CAC 100–399 | 13.8 | 14.0 | 12.3 | 12.8 | 11.4 |
| CAC ≥400 | 11.0 | 11.0 | 10.1 | 10.4 | 10.8 |
ASCVD indicates atherosclerotic cardiovascular disease; CAC, coronary artery calcium; CHD, coronary heart disease; HDL‐C, high‐density lipoprotein cholesterol.
a
Values are means±SD and percentages; percentages may not total 100 because of rounding.
b
ASCVD risk score is as estimated by the Pooled Cohort Equations.